Affinity-Tagged Antisense Probes for rRNA Depletion in FFPE Samples

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods are inadequate for effectively removing degraded rRNA from samples, particularly from formalin-fixed paraffin-embedded (FFPE) tissue sections, which hinders analysis of other RNA molecules of interest in gene expression studies and clinical diagnostics.

Innovation Solution

The development of affinity-tagged antisense rRNA molecules complementary to specific rRNA sequences, which are used to generate rRNA-depleted samples or isolate rRNA, utilizing a binding matrix to remove rRNA molecules, thereby enhancing the analysis of non-rRNA molecules.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional methods are used to remove rRNA from samples, then some rRNA removal is achieved, but degraded rRNA from FFPE tissue sections cannot be effectively removed

Engineering Contradiction:
ImproverRNA removal effectivenessVSAvoidapplicability to degraded RNA samples
Core Design Contradiction:
ReliabilityVSAdaptability or versatility

Solution Approach 1:

The patent employs RNase H enzyme which recognizes RNA-DNA hybrid structures and selectively degrades the RNA component. This enzymatic approach changes the mechanism from physical/chemical removal to biological recognition, enabling effective degradation of rRNA including fragmented forms in FFPE samples while preserving other RNA molecules

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The invention uses oligonucleotide probes as intermediaries that hybridize to target rRNA sequences. These probes serve as mediators between the detection system and the rRNA molecules, enabling specific recognition and subsequent removal of rRNA through RNase H-mediated degradation

Inventive Principle:
Principle #24Intermediary (Mediator)

2Stability of the object's composition

If rRNA is present in samples, then the natural RNA composition is maintained, but analysis of other RNA molecules is complicated

Engineering Contradiction:
ImproveRNA composition integrityVSAvoidanalysis accuracy of non-rRNA molecules
Core Design Contradiction:
Stability of the object's compositionVSMeasurement precision

Solution Approach 1:

The patent selectively removes rRNA from the total RNA population using RNase H-mediated degradation. This extraction of the problematic component (rRNA) allows the remaining RNA molecules to be analyzed without interference, improving measurement precision for gene expression studies while maintaining the integrity of the original sample composition through targeted removal

Inventive Principle:
Principle #2Taking out (Extraction)

3Ease of manufacture

If degraded rRNA from FFPE samples is not effectively removed, then sample preparation is simplified, but valuable clinical information remains inaccessible

Engineering Contradiction:
Improvesample preparation simplicityVSAvoidclinical RNA information
Core Design Contradiction:
Ease of manufactureVSLoss of information

Solution Approach 1:

The RNase H enzyme performs self-service by automatically recognizing and degrading rRNA sequences through its catalytic activity. The system uses the complementary base pairing between oligonucleotide probes and rRNA to guide the enzymatic degradation, eliminating the need for complex manual intervention while effectively removing degraded rRNA to recover clinical information

Inventive Principle:
Principle #25Self-service

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach allows for the generation of rRNA-depleted samples that are substantially free of rRNA sequences, enabling more accurate analysis of non-rRNA molecules, such as mRNA, miRNA, and other transcriptomic components, improving diagnostic and therapeutic applications.

Implementation Method 1

affinity-tagged antisense rRNA molecules that exhibit sequences complementary to substantially all of at least one full-length rRNA molecule

Methodology Applied
Scientific EffectNucleic acid hybridization:

Implementation Method 2

utilizing a binding matrix to remove rRNA molecules

Methodology Applied
Scientific EffectAffinity binding:

Data Source

PatentUS10435683B2Methods, compositions, and kits for generating rRNA-depleted samples or isolating rRNA from samples
Publication Date: 2019.10.08 ILLUMINA INC
  • US10435683B2 patent drawing
  • US10435683B2 patent drawing
  • US10435683B2 patent drawing

AI summary

The present invention provides methods, compositions, and kits for generating rRNA-depleted samples and for isolating rRNA from samples. In particular, the present invention provides compositions comprising affinity-tagged antisense rRNA molecules corresponding to substantially all of at least one rRNA molecule (e.g., 28S, 26S, 25S, 18S, 5.8S and 5S eukaryotic cytoplasmic rRNA molecules, 12S and 16S eukaryotic mitochondrial rRNA molecules, and 23S, 16S and 5S prokaryotic rRNA molecules) and methods for using such compositions to generate rRNA-depleted samples or to isolate rRNA molecules from samples.